Exact Mass: 408.2876

Exact Mass Matches: 408.2876

Found 500 metabolites which its exact mass value is equals to given mass value 408.2876, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Cholic acid

(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O5 (408.2876)


Cholic acid is a bile acid that is 5beta-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12. It has a role as a human metabolite and a mouse metabolite. It is a bile acid, a C24-steroid, a 3alpha-hydroxy steroid, a 7alpha-hydroxy steroid, a 12alpha-hydroxy steroid and a trihydroxy-5beta-cholanic acid. It is a conjugate acid of a cholate. Cholic acid is a metabolite found in or produced by Escherichia coli (strain K12, MG1655). Cholic acid is a Bile Acid. Cholic acid is a naturally occurring bile acid that is used to treat patients with genetic deficiencies in the synthesis of bile acids. When given in high doses, cholic acid replacement therapy has been linked to minor elevations in serum aminotransferase levels, but it has not been linked to instances of clinically apparent acute liver injury with jaundice. Cholic acid is a natural product found in Caenorhabditis elegans, Bufo bufo, and Homo sapiens with data available. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. (A3407, A3408, A3409, A3410). A major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. See also: Cholic acid; ferrous gluconate; honey (component of). Cholic acid is a major primary bile acid produced in the liver and is usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, and depends only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine, and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH, and consequently require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). When present in sufficiently high levels, cholic acid can act as a hepatotoxin and a metabotoxin. A hepatotoxin causes damage to the liver or liver cells. A metabotoxin is an endogenously produced metabolite that causes adverse health effects at chronically high levels. Among the primary bile acids, cholic acid is considered to be the least hepatotoxic while deoxycholic acid is the most hepatoxic (PMID: 1641875). The liver toxicity of bile acids appears to be due to their ability to peroxidate lipids and to lyse liver cells. Chronically high levels of cholic acid are associated with familial hypercholanemia. In hypercholanemia, bile acids, including cholic acid, are elevated in the blood. This disease causes liver damage, extensive itching, poor fat absorption, and can lead to rickets due to lack of calcium in bones. The deficiency of normal bile acids in the intestines results in a deficiency of vitamin K, which also adversely affects clotting of the blood. The bile acid ursodiol (ursodeoxycholic acid) can improve symptoms associated with familial hypercholanemia. Cholic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=81-25-4 (retrieved 2024-06-29) (CAS RN: 81-25-4). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2]. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].

   

α-Muricholic acid

(4R)-4-[(1S,2R,5R,7R,8S,9S,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


alpha-Muricholic acid is a hydroxylated bile acid present in normal human urine (PMID: 1629271), and in free glycine-conjugated, taurine-conjugated, and sulfated forms in human feces (PMID: 3667743). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). a-Muricholic acid is an hydroxylated bile acid present in normal human urine (PMID 1629271), and free, glycine-conjugated, taurine-conjugated and sulphated forms in human feces (PMID 3667743). α-Muricholic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=2393-58-0 (retrieved 2024-06-29) (CAS RN: 2393-58-0). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0).

   
   

1b,3a,7a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,3R,5S,7S,9R,10S,11S,14R,15R)-3,5,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


1b,3a,7a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. [HMDB] D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

Phocaecholic acid

beta-Phocaecholate; beta-Phocaecholic acid; (23R)-Hydroxychenodeoxycholate

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts

   

Bitocholic acid

(23R)-3α,12α,23-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


Bitocholic acid is a bile acid, which is a type of steroid acid found in the bile of mammals. It is synthesized from cholesterol in the liver and plays a crucial role in the digestion and absorption of lipid-soluble vitamins and the metabolism of lipids and cholesterol. Bitocholic acid is a specific type of bile acid, although it is not commonly found in nature and may be produced under certain conditions or through chemical synthesis.

   

Avicholic acid

3α,7α,16α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


A trihydroxy-5beta-cholanic acid that is 5beta-cholan-24-oic acid substituted by hydroxy groups at positions 3, 7 and 16 (the 3alpha,7alpha,16alpha stereoisomer). It is a major constituent of the bile of several avian species. Avicholic acid is a bile acid, which is a type of steroid acid found in the bile of mammals. It is synthesized from cholesterol in the liver and plays a crucial role in the digestion and absorption of lipid-soluble vitamins and the metabolism of lipids and cholesterol. Avicholic acid is a specific type of bile acid, although it is not commonly found in nature and may be produced under certain conditions or through chemical synthesis.

   

Haemulcholic acid

Haemulcholate; Hemulcholic acid; 3alpha,7alpha,22-Trihydroxy-5beta-cholan-24-oic acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

Cygnocholic acid

Cygnocholate; Cygnocholic acid; 3alpha,7alpha,15alpha-Trihydroxy-5beta-cholan-24-oic acid

C24H40O5 (408.2876)


   

3a,6a,7b-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2R,5R,7R,8R,9R,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,6a,7b-Trihydroxy-5b-cholanoic acid is an unusual trihydroxy bile acid found in the urine of healthy humans, mainly in newborns (PMID 3769218). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 6, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). 3a,6a,7b-Trihydroxy-5b-cholanoic acid is an unusual trihydroxy bile acid found in the urine of healthy humans, mainly in newborns (PMID 3769218). D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

β-Muricholic acid

(4R)-4-[(1S,2R,5R,7R,8S,9R,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,6b,7b-Trihydroxy-5b-cholanoic acid, also known as beta-muricholic acid, is a bile acid. 3a,6b,7b-Trihydroxy-5b-cholanoic acid belongs to the class of compounds known muricholic acids in which the hydroxy groups at positions 6 and 7 both have a beta configuration. It is also classified as a 6beta-hydroxy steroid, a 7beta-hydroxy steroid, a steroid acid and a bile acid. Muricholic acids are a group of bile acids that are particularly abundant in mice, which gives them their name. Muricholic acids are also found at low concentrations in other mammalian species, including humans (PMID: 12543708). Muricholic acids differ from the primary bile acids found in humans (which are cholic acid and chenodeoxycholic acid) by having a hydroxyl group in the beta-conformation at the 6-position. The orientation of the hydroxyl group at the 7 position defines alpha- or beta-muricholic acid. Muricholic acids are detectable at low concentrations in human urine (PMIDL 1629271). The enzyme responsible for the 6-hydroxylation reactions forming muricholates in rodents is the cytochrome P450 Cyp2c70. This produces alpha-muricholic acid from chenodeoxycholic acid, and beta-muricholic acid from ursodeoxycholic acid. Bile acids, such as muricholic acid, are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 6, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). 3a,6b,7b-Trihydroxy-5b-cholanoic acid is a bile acid found in urine exhibiting a complex modification pattern, including free, glyco- and sulfoconjugated forms (PMID 3834660). β-Muricholic acid is a potent and orally active biliary cholesterol-desaturating agent. β-Muricholic acid prevents cholesterol gallstones. β-Muricholic acid inhibits lipid accumulation. β-Muricholic acid has the potential for the research of nonalcoholic fatty liver disease (NAFLD)[1][2].

   

Allocholic acid

(4R)-4-[(1S,2S,5R,7R,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


Allocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). [Analytical] Sample of 1 micorL methanol solution was flow injected. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids CONFIDENCE standard compound; INTERNAL_ID 271 Allocholic acid is a typically fetal bile acid found in vertebrates and reappears during liver regeneration and carcinogenesis, besides it is also a conjugate acid of allocholate and an isomer of cholic acid. Allocholic acid is a potent and specific stimulant of the adult olfactory system, it has a role as a marine metabolite, a rat metabolite and a human metabolite[1][2][3].

   

Ursocholic acid

(4R)-4-[(1S,2S,5R,7S,9S,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


Ursocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). Ursocholic acid is the 7 beta-hydroxyepimer of cholic acid. It induces a reduction of bile cholesterol saturation. A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Ursocholic acid. CAS Common Chemistry. CAS, a division of the American Chemical Society, n.d. https://commonchemistry.cas.org/detail?cas_rn=2955-27-3 (retrieved 2024-07-16) (CAS RN: 2955-27-3). Licensed under the Attribution-Noncommercial 4.0 International License (CC BY-NC 4.0). Ursocholic acid, a bile acid found predominantly in bile of mammals, is transformed into deoxycholic acid by the intestinal microflora in mice. Ursodeoxycholic acid is an inhibitor of 7α-hydroxysteroid dehydrogenase and hepatocyte nuclear factor 1α[1].

   

Hyocholic Acid

3alpha,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


A trihydroxy-5beta-cholanic acid in which the three hydroxy substituents are located at the 3alpha-, 6alpha- and 7alpha-positions. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids CONFIDENCE standard compound; INTERNAL_ID 267

   

Bile acid

Bile acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts

   

3alpha,7alpha,16alpha-trihydroxy-5alpha-cholan-24-oic Acid

3alpha,7alpha,16alpha-trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,7alpha,12beta-Trihydroxy-5beta-cholan-24-oic Acid

(4S)-4-[(3R,5S,7R,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

Cholic Acid

3alpha,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic acid

C24H40O5 (408.2876)


Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2]. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].

   

3alpha,7alpha,12beta-Trihydroxy-5beta-cholanoic acid

(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16R)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3alpha,7alpha,12beta-Trihydroxy-5beta-cholanoic acid, also known as lagocholic acid, is a bile acid. Bile acids with beta-hydroxyl and carbonyl groups at the C-3,7, and/or 12 positions are bile acids usually found in the urine of healthy humans (PMID: 8743575). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy > A05AA - Bile acids and derivatives C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Same as: D10699 Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2]. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].

   

1b,3a,12a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(2S,3R,5S,15R,16S)-3,5,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


1b,3a,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues.

   

Sinapoylspermine

(2Z)-N-(3-aminopropyl)-N-{4-[(3-aminopropyl)amino]butyl}-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enamide

C21H36N4O4 (408.2736)


Sinapoylspermine is found in brassicas. Sinapoylspermine is an alkaloid from Brassica oleracea var. botrytis (cauliflower). Alkaloid from Brassica oleracea variety botrytis (cauliflower). Sinapoylspermine is found in brassicas.

   

6a,12a-Dihydroxylithocholic acid

(4R)-4-[(1S,2R,5R,8S,10R,11S,14R,15R,16S)-5,8,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


6a,12a-Dihydroxylithocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). 6a,12a-Dihydroxylithocholic acid has been identified in the urine of patients with cholestasis (PMID 7444367). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

Ganodosterone

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadeca-6,9-diene-5,8-dione

C28H40O2 (408.3028)


Ganodosterone is found in mushrooms. Ganodosterone is isolated from the fungus Ganoderma lucidum (reishi). Isolated from the fungus Ganoderma lucidum (reishi). Ganodosterone is found in mushrooms.

   

Apo-10'-violaxanthal

(2Z,4Z,6E,8E,10E,12Z,14E)-15-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-4,9,13-trimethylpentadeca-2,4,6,8,10,12,14-heptaenal

C27H36O3 (408.2664)


Apo-10-violaxanthal is found in citrus. Apo-10-violaxanthal is isolated from Valencia orange peels. Isolated from Valencia orange peels. Apo-10-violaxanthal is found in sweet orange and citrus.

   

3a,4b,7a-Trihydroxy-5b-cholanoic acid

(4S)-4-[(1S,2R,5R,6R,7S,9R,10S,11S,15R)-5,6,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,4b,7a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. 3a,4b,7a-Trihydroxy-5b-cholanoic acid accounts for 5-15\\% of the total biliary bile acids in early gestation, has been identified in the feces from healthy newborn infants many days after birth, indicating a hepatic origin for C-4 hydroxylation of bile acids. PMID 2794778). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. 3a,4b,7a-Trihydroxy-5b-cholanoic acid accounts for 5-15\\% of the total biliary bile acids in early gestation, has been identified in the feces from healthy newborn infants many days after birth, indicating a hepatic origin for C-4 hydroxylation of bile acids. PMID 2794778) [HMDB]

   

3a,4b,12a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,5R,7R,10R,11S,14R,15R)-5-Hydroxy-2,15-dimethyl-16-oxotetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoate

C24H40O5 (408.2876)


3a,4b,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

1,3,12-Trihydroxycholan-24-oic acid

(4R)-4-[(1S,2S,10S,11S,14R,15R)-3,5,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


1,3,12-Trihydroxycholan-24-oic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135).

   

3b,7a,12a-Trihydroxy-5a-Cholanoic acid

(4R)-4-[(1S,2S,5S,7R,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3b,7a,12a-Trihydroxy-5a-Cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. 3b,7a,12a-Trihydroxy-5a-Cholanoic acid has been identified in the bile, plasma and urine of patients with delta 4-3-oxosteroid 5 beta-reductase deficiency with neonatal hepatitis, an inborn error in bile acid synthesis. (PMID 3198770). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. 3b,7a,12a-Trihydroxy-5a-Cholanoic acid has been identified in the bile, plasma and urine of patients with delta 4-3-oxosteroid 5 beta-reductase deficiency with neonatal hepatitis, an inborn error in bile acid synthesis. (PMID 3198770) [HMDB]

   

3a,7b,12b-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,5R,7S,9S,10R,11S,14R,15R,16R)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,7b,12b-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

3b,7b,12a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,5S,7S,9S,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3b,7b,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). 3b,7b,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

2b,3a,7a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,4S,5S,7R,9R,10R,11S,14R,15R)-4,5,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


2b,3a,7a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

3b,7a,12a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(1S,2S,5S,7S,9R,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3b,7a,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135).

   

3b,7b,12a-Trihydroxy-5a-Cholanoic acid

(4R)-4-[(1S,2S,5S,7R,9S,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3b,7b,12a-Trihydroxy-5a-Cholanoic acid is a bile acid present in the urine of healthy humans, predominantly found in the glycine conjugate fraction (PMID 864325). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. [HMDB] 3b,7b,12a-Trihydroxy-5a-Cholanoic acid is a bile acid present in the urine of healthy humans, predominantly found in the glycine conjugate fraction (PMID 864325). Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

3a,7b,12a-Trihydroxy-5a-Cholanoic acid

(4R)-4-[(1S,2S,5R,7R,9S,10R,11S,14R,15R,16S)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3a,7b,12a-Trihydroxy-5a-Cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135).

   

Hyocholate

(4R)-4-[(1S,2R,5R,7R,8R,9S,10S,11S,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


Hyocholic acid is a bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). A bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

Muricholic acid

(4R)-4-[(1S,2R,5R,7R,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


A bile acid. Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

N-Linoleoyl Glutamine

4-(C-Hydroxycarbonimidoyl)-2-[(1-hydroxyoctadeca-9,12-dien-1-ylidene)amino]butanoate

C23H40N2O4 (408.2988)


N-linoleoyl glutamine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Linoleic acid amide of Glutamine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Linoleoyl Glutamine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Linoleoyl Glutamine is therefore classified as a long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.

   

3,6,7-Trihydroxycholan-24-oic acid

3,6,7-Trihydroxycholan-24-oic acid

C24H40O5 (408.2876)


   

Allocholate

4-{5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl}pentanoic acid

C24H40O5 (408.2876)


Allocholic acid is a typically fetal bile acid found in vertebrates and reappears during liver regeneration and carcinogenesis, besides it is also a conjugate acid of allocholate and an isomer of cholic acid. Allocholic acid is a potent and specific stimulant of the adult olfactory system, it has a role as a marine metabolite, a rat metabolite and a human metabolite[1][2][3].

   

Butaprost

Methyl 7-{3-hydroxy-2-[4-hydroxy-4-(1-propylcyclobutyl)but-1-en-1-yl]-5-oxocyclopentyl}heptanoic acid

C24H40O5 (408.2876)


   

QUINGESTANOL ACETATE

(3-cyclopentyloxy-17-ethynyl-13-methyl-2,7,8,9,10,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl) acetate

C27H36O3 (408.2664)


   

Sargachromanol P

Sargachromanol P

C27H36O3 (408.2664)


   

Aculeatol D

Aculeatol D

C24H40O5 (408.2876)


   

Tasnemoxide A

Tasnemoxide A

C24H40O5 (408.2876)


   

iso-Spiculoic acid A

(+)-iso-Spiculoic acid A

C27H36O3 (408.2664)


   

Gymnasterone C

Gymnasterone C

C28H40O2 (408.3028)


   

Diacarnoxide A

Diacarnoxide A

C25H44O4 (408.3239)


   

Diacarnoxide C

Diacarnoxide C

C25H44O4 (408.3239)


   

Tasnemoxide B

Tasnemoxide B

C24H40O5 (408.2876)


   
   

12,28-Oxaircinal A

12,28-Oxaircinal A

C26H36N2O2 (408.2777)


   
   

2beta,15-Dihydroxy-ent-7-labdene-2-O-methylmalonate

2beta,15-Dihydroxy-ent-7-labdene-2-O-methylmalonate

C24H40O5 (408.2876)


   

Epimuqubilin B

Epimuqubilin B

C24H40O5 (408.2876)


   

Anisodorin 5

Anisodorin 5

C24H40O5 (408.2876)


   

Cholic Acid

sodium cholate hydrate

C24H40O5 (408.2876)


MS2 deconvoluted using MS2Dec from all ion fragmentation data, MetaboLights identifier MTBLS1040; BHQCQFFYRZLCQQ-OELDTZBJSA-N_STSL_0091_Cholic acid_8000fmol_180416_S2_LC02_MS02_85; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. MS2 deconvoluted using CorrDec from all ion fragmentation data, MetaboLights identifier MTBLS1040; Spectrum acquired as described in Naz et al 2017 PMID 28641411. Preparation and submission to MassBank of North America by Chaleckis R. and Tada I. relative retention time with respect to 9-anthracene Carboxylic Acid is 1.368 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.366 relative retention time with respect to 9-anthracene Carboxylic Acid is 1.369 Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2]. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].

   

MCULE-3591387207

MCULE-3591387207

C24H40O5 (408.2876)


   

alpha-muricholic acid

3a,6b,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids [Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

8-hydroxy-13E-labden-15-yl-methyl malonic acid diester

8-hydroxy-13E-labden-15-yl-methyl malonic acid diester

C24H40O5 (408.2876)


   

Plastoquinone 4

Plastoquinone 4

C28H40O2 (408.3028)


   

atomarianone A

atomarianone A

C27H36O3 (408.2664)


   

negombatoperoxide A

negombatoperoxide A

C24H40O5 (408.2876)


   

spiculoic acid A

spiculoic acid A

C27H36O3 (408.2664)


A carbobicyclic compound that is 2,3,3a,4,5,7a-hexahydro-1H-indene substituted by ethyl groups at positions 3, 4, 5 and 7, a methyl group at position 1, an oxo group at position 2, a 2-phenylethenyl group at position 5 and a carboxy group at position 4 (the 1R,3R,3aS,4S,5R,7aS stereoisomer). Isolated from Plakortis angulospiculatus, it exhibits cytotoxicity against human breast cancer MCF-7 cells.

   

hirsutalin E

hirsutalin E

C24H40O5 (408.2876)


A natural product found in Cladiella hirsuta.

   

chromarol E

chromarol E

C27H36O3 (408.2664)


   

(3alpha,5beta,12alpha,16alpha)-3,12,16-Trihydroxycholan-24-oic acid

(3alpha,5beta,12alpha,16alpha)-3,12,16-Trihydroxycholan-24-oic acid

C24H40O5 (408.2876)


   

rhopaloic acid G

rhopaloic acid G

C24H40O5 (408.2876)


   

18-methylmalonyltrinerdiol

18-methylmalonyltrinerdiol

C24H40O5 (408.2876)


   

15,16-diacetyl-trinertriol

15,16-diacetyl-trinertriol

C24H40O5 (408.2876)


   
   

4,7,10,13,16,19,22,25-octacosaoctaenoic acid

4,7,10,13,16,19,22,25-octacosaoctaenoic acid

C28H40O2 (408.3028)


   

Gerronemin E

Gerronemin E

C27H36O3 (408.2664)


   

8beta,15-dihydroxy-18-angeloyloxy-ent-labdane

8beta,15-dihydroxy-18-angeloyloxy-ent-labdane

C25H44O4 (408.3239)


   

2beta,3alpha,15-Trihydroxy-ent-labd-7-ene 2,15-diacetate

2beta,3alpha,15-Trihydroxy-ent-labd-7-ene 2,15-diacetate

C24H40O5 (408.2876)


   

3,3-dimethyl-1,2,3,4,5,6,1,2,3,4,5,6,9,10-tetradecahydro-[9,10]bi[1,5-methano-pyrido[1,2-a][1,5]diazocinyl]-8,8-dione|Dimethamin

3,3-dimethyl-1,2,3,4,5,6,1,2,3,4,5,6,9,10-tetradecahydro-[9,10]bi[1,5-methano-pyrido[1,2-a][1,5]diazocinyl]-8,8-dione|Dimethamin

C24H32N4O2 (408.2525)


   
   
   

acutilactone

acutilactone

C25H44O4 (408.3239)


   

prugosene C1

prugosene C1

C27H36O3 (408.2664)


   

(22E)-3beta-hydroxyergosta-5,8,14,22-tetraen-7-one

(22E)-3beta-hydroxyergosta-5,8,14,22-tetraen-7-one

C28H40O2 (408.3028)


   

(1R*,2R*,3R*,6S*,7S*,9R*,10R*,14R*)-3-butanoyloxycladiell-11(17)-en-6,7-diol

(1R*,2R*,3R*,6S*,7S*,9R*,10R*,14R*)-3-butanoyloxycladiell-11(17)-en-6,7-diol

C24H40O5 (408.2876)


   

4-hydroxy-5-(11-hydroxy-3,7,11-trimethyldodeca-2,6-dienyl)-2,3-dimethoxy-6-methylcyclohex-2-en-1-one

4-hydroxy-5-(11-hydroxy-3,7,11-trimethyldodeca-2,6-dienyl)-2,3-dimethoxy-6-methylcyclohex-2-en-1-one

C24H40O5 (408.2876)


   

(?)-9,10-epoxymuqubilin A

(?)-9,10-epoxymuqubilin A

C24H40O5 (408.2876)


   

(R)-3,5-dihydroxy-7-(16-hydroxyheptadecyl)benzoic acid

(R)-3,5-dihydroxy-7-(16-hydroxyheptadecyl)benzoic acid

C24H40O5 (408.2876)


   

20-hydroxyergosta-4,6,8(14),22-tetraen-3-one

20-hydroxyergosta-4,6,8(14),22-tetraen-3-one

C28H40O2 (408.3028)


   

(R)-3,5-dihydroxy-7-(15-hydroxyheptadecyl)benzoic acid

(R)-3,5-dihydroxy-7-(15-hydroxyheptadecyl)benzoic acid

C24H40O5 (408.2876)


   

ganodermaside A

ganodermaside A

C28H40O2 (408.3028)


   

15,18-diacetyl-trinertriol

15,18-diacetyl-trinertriol

C24H40O5 (408.2876)


   

25-hydroxyergosta-4,6,8(14),22-tetraen-3-one

25-hydroxyergosta-4,6,8(14),22-tetraen-3-one

C28H40O2 (408.3028)


   

Byssomeruliol E

Byssomeruliol E

C24H40O5 (408.2876)


   

tarapacol diacetate

tarapacol diacetate

C24H40O5 (408.2876)


   

ent-16alpha-hydroxy-2alpha-hydroxybenzylatis-13-en-3-one

ent-16alpha-hydroxy-2alpha-hydroxybenzylatis-13-en-3-one

C27H36O3 (408.2664)


   

8beta,15-dihydroxy-18-senecioyloxy-ent-labdane

8beta,15-dihydroxy-18-senecioyloxy-ent-labdane

C25H44O4 (408.3239)


   

callophycoic acid F

callophycoic acid F

C27H36O3 (408.2664)


An organic heterobicyclic compound that is 2,5-dihydro-1-benzoxepine-7-carboxylic acid substituted by a (3E,7E)-4,8,12-trimethyltrideca-3,7,11-trien-1-yl group at position 3. It is isolated from the Fijian red alga Callophycus serratus and exhibits antibacterial, antimalarial and anticancer activities.

   

Aspergillus acid A

Aspergillus acid A

C24H40O5 (408.2876)


   

N-linoleoyl-L-glutamine|N-linolyl-L-glutamine

N-linoleoyl-L-glutamine|N-linolyl-L-glutamine

C23H40N2O4 (408.2988)


   

ptychantin M

ptychantin M

C24H40O5 (408.2876)


   

3,11-diacetoxy-15,16-dehydrocembran-6-one

3,11-diacetoxy-15,16-dehydrocembran-6-one

C24H40O5 (408.2876)


   

3alpha,7beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,7beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

3beta,7alpha,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


A trihydroxy-5beta-cholanic acid that is 5beta-cholan-24-oic acid substituted by hydroxy groups at positions 3, 7 and 12 (the 3beta,7alpha,12alpha stereoisomer). [Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

3beta,7beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7alpha,12beta-Trihydroxy-5beta-cholan-24-oic Acid

3beta,7alpha,12beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

3beta,7beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3alpha,7beta,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

3alpha,7beta,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3alpha,7alpha,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

3alpha,7alpha,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3alpha,7beta,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

3alpha,7beta,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7alpha,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

3beta,7alpha,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7beta,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

3beta,7beta,12alpha-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7alpha,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

3beta,7alpha,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3beta,7beta,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

3beta,7beta,12beta-Trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.

   

1b,3a,7a-Trihydroxy-5b-cholan-24-Oic acid

1b,3a,7a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

1b,3a,12a-Trihydroxy-5b-cholan-24-Oic acid

1b,3a,12a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

2b,3a,7a-Trihydroxy-5b-cholan-24-Oic acid

2b,3a,7a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

2b,3a,12a-Trihydroxy-5b-cholan-24-oic acid

2b,3a,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3a,4b,7a-Trihydroxy-5b-cholan-24-Oic acid

3a,4b,7a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3b,4b,7a-Trihydroxy-5b-cholan-24-oic acid

3b,4b,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3a,4b,12a-Trihydroxy-5b-cholan-24-oic acid

3a,4b,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3b,4b,12a-Trihydroxy-5b-cholan-24-oic acid

3b,4b,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3b,4a,12a-Trihydroxy-5b-cholan-24-oic acid

3b,4a,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3a,6a,7a-Trihydroxy-5b-cholan-24-Oic acid

3a,6a,7a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay [Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-source decay

   

3a,6a,7b-Trihydroxy-5b-cholan-24-Oic acid

3a,6a,7b-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay In-suorce decay; [Mass_spectrometry] Sampling interval 1 Hz; [Analytical] Sample of 1 micorL methanol solution was flow injected.

   

3a,6b,7a-Trihydroxy-5b-cholan-24-oic acid

3a,6b,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3a,6b,7b-Trihydroxy-5b-cholan-24-Oic acid

3a,6b,7b-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6a,7a-Trihydroxy-5b-cholan-24-oic acid

3b,6a,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6a,7b-Trihydroxy-5b-cholan-24-oic acid

3b,6a,7b-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6b,7a-Trihydroxy-5b-cholan-24-oic acid

3b,6b,7a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6b,7b-Trihydroxy-5b-cholan-24-oic acid

3b,6b,7b-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3a,6a,12a-Trihydroxy-5b-cholan-24-Oic acid

3a,6a,12a-Trihydroxy-5b-cholan-24-Oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay In-suorce decay; [Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz

   

3a,6b,12a-Trihydroxy-5b-cholan-24-oic acid

3a,6b,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6a,12a-Trihydroxy-5b-cholan-24-oic acid

3b,6a,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   

3b,6b,12a-Trihydroxy-5b-cholan-24-oic acid

3b,6b,12a-Trihydroxy-5b-cholan-24-oic acid

C24H40O5 (408.2876)


[Analytical] Sample of 1 micorL methanol solution was flow injected.; [Mass_spectrometry] Sampling interval 1 Hz; In-suorce decay

   
   

C24H40O5_4-{[5-(7-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

NCGC00380160-01_C24H40O5_4-{[5-(7-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

C24H40O5 (408.2876)


   

C24H40O5_4-{[5-(6-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

NCGC00380550-01_C24H40O5_4-{[5-(6-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

C24H40O5 (408.2876)


   

3a,6a,7b-Trihydroxy-5b-cholanoic acid

3a,6a,7b-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

3-Cholic acid

3-Cholic acid

C24H40O5 (408.2876)


CONFIDENCE standard compound; INTERNAL_ID 301

   

3a,6a,7b-(OH)3-5a-cholanic acid

3a,6a,7b-(OH)3-5a-cholanic acid

C24H40O5 (408.2876)


BA-99-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-99-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-99-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,6b,7b-Trihydroxy-5a-cholan-24-oic acid

3a,6b,7b-Trihydroxy-5a-cholan-24-oic acid

C24H40O5 (408.2876)


BA-100-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-100-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-100-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,14a-(OH)3-5b-cholanic acid

3a,7a,14a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-103-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-103-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-103-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-103-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7b,14a-(OH)3-5b-cholanic acid

3a,7b,14a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-104-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-104-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-104-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-104-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,15a-(OH)3-5b-cholanic acid

3a,7a,15a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-105-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-105-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-105-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-105-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,15b-(OH)3-5b-cholanic acid

3a,7a,15b-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-106-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-106-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-106-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-106-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7b,15b-(OH)3-5b-cholanic acid

3a,7b,15b-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-107-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-107-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-107-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-107-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,16a-(OH)3-5b-cholanic acid

3a,7a,16a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-108-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-108-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-108-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,16b-(OH)3-5b-cholanic acid

3a,7a,16b-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-109-150. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-109-120. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-109-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-109-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-109-30. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   

3a,7a,17a-(OH)3-5b-cholanic acid

3a,7a,17a-(OH)3-5b-cholanic acid

C24H40O5 (408.2876)


BA-110-90. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan. BA-110-60. In-source decay; 1 microL of the bile acid in MeOH solution was flow injected. Sampling interval was 1 Hz.; This record was created by the financial support of MEXT/JSPS KAKENHI Grant Number 17HP8021 (2017) to the MassBank database committee of the Mass Spectrometry Society of Japan.

   
   

Cholic acid; LC-tDDA; CE10

Cholic acid; LC-tDDA; CE10

C24H40O5 (408.2876)


   

Cholic acid; LC-tDDA; CE20

Cholic acid; LC-tDDA; CE20

C24H40O5 (408.2876)


   

Cholic acid; LC-tDDA; CE30

Cholic acid; LC-tDDA; CE30

C24H40O5 (408.2876)


   

Cholic acid; LC-tDDA; CE40

Cholic acid; LC-tDDA; CE40

C24H40O5 (408.2876)


   

Ursocholic acid

3alpha,7beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


A bile acid that is 5beta-cholan-24-oic acid bearing three hydroxy substituents at positions 3alpha, 7beta and 12alpha. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Ursocholic acid, a bile acid found predominantly in bile of mammals, is transformed into deoxycholic acid by the intestinal microflora in mice. Ursodeoxycholic acid is an inhibitor of 7α-hydroxysteroid dehydrogenase and hepatocyte nuclear factor 1α[1].

   

Cholic Acid_major

Cholic Acid_major

C24H40O5 (408.2876)


   

Cholic Acid_88.5\\%

Cholic Acid_88.5\\%

C24H40O5 (408.2876)


   

(R)-4-((3R,5S,7S,8S,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5S,7S,8S,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5R,6R,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,6R,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((1R,3S,5S,7R,8S,9S,10S,13R,14S,17R)-1,3,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((1R,3S,5S,7R,8S,9S,10S,13R,14S,17R)-1,3,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5S,7R,8R,9S,10S,13S,14S,16R)-3,7,16-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5S,7R,8R,9S,10S,13S,14S,16R)-3,7,16-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5R,6R,8R,9S,10R,12S,13R,14S,17R)-3,6,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,6R,8R,9S,10R,12S,13R,14S,17R)-3,6,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5S,7S,8R,9S,10S,12R,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5S,7S,8R,9S,10S,12R,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5R,6R,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5R,6R,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5R,6R,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5R,6R,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3S,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3S,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6R,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6R,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6S,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6S,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6S,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5R,6R,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,6R,7S,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(2R,4R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxypentanoic acid

"(2R,4R)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxypentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6S,7S,9S,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6S,7S,9S,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5S,7R,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5S,7R,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,4R,5S,7R,9S,10R,13R,14S,17R)-3,4,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,4R,5S,7R,9S,10R,13R,14S,17R)-3,4,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5S,7S,9S,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5S,7S,9S,10S,12S,13R,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((2S,3S,5R,7R,9S,10S,13R,14S,17R)-2,3,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((2S,3S,5R,7R,9S,10S,13R,14S,17R)-2,3,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5S,7R,9S,10S,13R,14S,15R,17R)-3,7,15-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5S,7R,9S,10S,13R,14S,15R,17R)-3,7,15-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5S,7R,9S,10S,13R,14S,15S,17R)-3,7,15-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5S,7R,9S,10S,13R,14S,15S,17R)-3,7,15-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3S,5R,6R,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3S,5R,6R,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(2S,4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxypentanoic acid

"(2S,4R)-4-((3R,5S,7R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxypentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6R,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6R,7R,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3S,5S,7S,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3S,5S,7S,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3S,5R,6S,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3S,5R,6S,7S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6R,9S,10R,12S,13R,14S,17R)-3,6,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6R,9S,10R,12S,13R,14S,17R)-3,6,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5S,7S,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5S,7S,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5R,6S,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5R,6S,7R,8S,9S,10R,13R,14S,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5S,7S,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5S,7S,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5S,7R,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5S,7R,8R,9S,10S,12R,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3S,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3S,5S,7S,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(3S,4S)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-3-hydroxypentanoic acid

"(3S,4S)-4-((3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-3-hydroxypentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,4R,5S,7R,8S,9S,10R,13R,14S,17R)-3,4,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,4R,5S,7R,8S,9S,10R,13R,14S,17R)-3,4,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(R)-4-((3R,5S,7R,8S,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(R)-4-((3R,5S,7R,8S,9S,10S,13R,14R,17R)-3,7,14-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(2S,4R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxypentanoic acid

"(2S,4R)-4-((3R,5R,8R,9S,10S,12S,13R,14S,17R)-3,12-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-hydroxypentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((3R,5R,6R,7R,8S,9S,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((3R,5R,6R,7R,8S,9S,10R,13R,17R)-3,6,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((1R,3S,5S,7R,9S,10S,13R,14S,17R)-1,3,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((1R,3S,5S,7R,9S,10S,13R,14S,17R)-1,3,7-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

(4R)-4-((1R,3S,5R,9S,10S,12S,13R,14S,17R)-1,3,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid

"(4R)-4-((1R,3S,5R,9S,10S,12S,13R,14S,17R)-1,3,12-trihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)pentanoic acid"

C24H40O5 (408.2876)


   

cholate

(4R)-4-[(3R,5S,7R,8R,9S,10S,12S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O5 (408.2876)


Cholic acid, also known as 3a,7a,12a-trihydroxy-5b-cholanate or cholate, belongs to trihydroxy bile acids, alcohols and derivatives class of compounds. Those are prenol lipids structurally characterized by a bile acid or alcohol which bears three hydroxyl groups. Thus, cholic acid is considered to be a bile acid lipid molecule. Cholic acid is practically insoluble (in water) and a weakly acidic compound (based on its pKa). Cholic acid can be found in a number of food items such as cocoa bean, walnut, garden rhubarb, and carob, which makes cholic acid a potential biomarker for the consumption of these food products. Cholic acid can be found primarily in bile, blood, feces, and urine, as well as throughout all human tissues. Cholic acid exists in all living organisms, ranging from bacteria to humans. In humans, cholic acid is involved in few metabolic pathways, which include bile acid biosynthesis, cerebrotendinous xanthomatosis (CTX), congenital bile acid synthesis defect type II, and congenital bile acid synthesis defect type III. Cholic acid is also involved in few metabolic disorders, which include 27-hydroxylase deficiency, familial hypercholanemia (FHCA), and zellweger syndrome. Moreover, cholic acid is found to be associated with biliary atresia, cirrhosis, cystic fibrosis, and primary biliary cirrhosis. Cholic acid is a non-carcinogenic (not listed by IARC) potentially toxic compound. A - Alimentary tract and metabolism > A05 - Bile and liver therapy > A05A - Bile therapy > A05AA - Bile acids and derivatives C78276 - Agent Affecting Digestive System or Metabolism > C66913 - Cholagogues or Choleretic Agents D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Same as: D10699 Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2]. Cholic acid is a major primary bile acid produced in the liver and usually conjugated with glycine or taurine. It facilitates fat absorption and cholesterol excretion. Cholic acid is orally active[1][2].

   

3,5,3,5-Tetra-tert-butyldiphenoquinone

3,5,3,5-Tetra-tert-butyldiphenoquinone

C28H40O2 (408.3028)


   

1β,3α,7α-Trihydroxy-5β-cholan-24-oic Acid

1β,3α,7α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,4β,7α-Trihydroxy-5β-cholan-24-oic Acid

3β,4β,7α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,5β,7α-Trihydroxycholan-24-oic Acid

3α,5β,7α-Trihydroxycholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,6α,7α-Trihydroxy-5β-cholan-24-oic Acid

3β,6α,7α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,6α,7β-Trihydroxy-5β-cholan-24-oic Acid

3β,6α,7β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,6β,7α-Trihydroxy-5β-cholan-24-oic Acid

3β,6β,7α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,6β,7β-Trihydroxy-5β-cholan-24-oic Acid

3β,6β,7β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,6α,7α-Trihydroxy-5α-cholan-24-oic Acid

3α,6α,7α-Trihydroxy-5α-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,6α,7β-Trihydroxy-5α-cholan-24-oic Acid

3α,6α,7β-Trihydroxy-5α-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,6β,7α-Trihydroxy-5α-cholan-24-oic Acid

3α,6β,7α-Trihydroxy-5α-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,6β,7β-Trihydroxy-5α-cholan-24-oic Acid

3α,6β,7β-Trihydroxy-5α-cholan-24-oic Acid

C24H40O5 (408.2876)


   

2β,3α,12α-Trihydroxy-5β-cholan-24-oic Acid

2β,3α,12α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,4β,12α-Trihydroxy-5β-cholan-24-oic Acid

3β,4β,12α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,5β,12α-Trihydroxycholan-24-oic Acid

3α,5β,12α-Trihydroxycholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,6β,12α-Trihydroxy-5β-cholan-24-oic Acid

3α,6β,12α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,6α,12α-Trihydroxy-5β-cholan-24-oic Acid

3β,6α,12α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,6β,12α-Trihydroxy-5β-cholan-24-oic Acid

3β,6β,12α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,7α,12β-Trihydroxy-5β-cholan-24-oic Acid

3β,7α,12β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,7β,12β-Trihydroxy-5β-cholan-24-oic Acid

3β,7β,12β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,7α,12β-Trihydroxy-5α-cholan-24-oic Acid

3α,7α,12β-Trihydroxy-5α-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,7α,12β-Trihydroxy-5α-cholan-24-oic Acid

3β,7α,12β-Trihydroxy-5α-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,7β,12β-Trihydroxy-5α-cholan-24-oic Acid

3α,7β,12β-Trihydroxy-5α-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,7β,12β-Trihydroxy-5α-cholan-24-oic Acid

3β,7β,12β-Trihydroxy-5α-cholan-24-oic Acid

C24H40O5 (408.2876)


   

(22R)-3α,7α,22-Trihydroxy-5β-cholan-24-oic Acid

(22R)-3α,7α,22-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

(23S)-3α,7α,23-Trihydroxy-5β-cholan-24-oic Acid

(23S)-3α,7α,23-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,9α,11β-Trihydroxy-5β-cholan-24-oic Acid

3α,9α,11β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,9α,11β-Trihydroxy-5β-cholan-24-oic Acid

3β,9α,11β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,11α,15β-Trihydroxy-5β-cholan-24-oic Acid

3α,11α,15β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,11β,15β-Trihydroxy-5β-cholan-24-oic Acid

3α,11β,15β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,12α,15α-Trihydroxy-5β-cholan-24-oic Acid

3α,12α,15α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,12α,16α-Trihydroxy-5β-cholan-24-oic Acid

3α,12α,16α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,15β,18-Trihydroxy-5β-cholan-24-oic Acid

3α,15β,18-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

1β,3α,7β-Trihydroxy-5β-cholan-24-oic Acid

1β,3α,7β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,5β,7β-Trihydroxycholan-24-oic Acid

3α,5β,7β-Trihydroxycholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,7β,21chi-Trihydroxy-5β-cholan-24-oic Acid

3α,7β,21chi-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,7β,22chi-Trihydroxy-5β-cholan-24-oic Acid

3α,7β,22chi-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

(23R)-3α,7β,23-Trihydroxy-5β-cholan-24-oic Acid

(23R)-3α,7β,23-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

(23S)-3α,7β,23-Trihydroxy-5β-cholan-24-oic Acid

(23S)-3α,7β,23-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,7α,19-Trihydroxy-5β-cholan-24-oic Acid

3α,7α,19-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,12α,19-Trihydroxy-5β-cholan-24-oic Acid

3α,12α,19-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

(23S)-3α,12α,23-Trihydroxy-5β-cholan-24-oic Acid

(23S)-3α,12α,23-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,12α,15β-Trihydroxy-5β-cholan-24-oic Acid

3α,12α,15β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3β,5α,6β-Trihydroxycholan-24-oic Acid

3β,5α,6β-Trihydroxycholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,11α,12α-Trihydroxy-5β-cholan-24-oic Acid

3α,11α,12α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,11α,12β-Trihydroxy-5β-cholan-24-oic Acid

3α,11α,12β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,11β,12α-Trihydroxy-5β-cholan-24-oic Acid

3α,11β,12α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,11β,12β-Trihydroxy-5β-cholan-24-oic Acid

3α,11β,12β-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,7α,15α-Trihydroxy-5β-cholan-24-oic Acid

3α,7α,15α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,7α,17α-Trihydroxy-5β-cholan-24-oic Acid

3α,7α,17α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,7β,14α-Trihydroxy-5β-cholan-24-oic Acid

3α,7β,14α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3α,7β,17α-Trihydroxy-5β-cholan-24-oic Acid

3α,7β,17α-Trihydroxy-5β-cholan-24-oic Acid

C24H40O5 (408.2876)


   

O-2545 (hydrochloride)

6a,7,10,10a-tetrahydro-3-[5-(1H-imidazol-1-yl)-1,1-dimethylpentyl]-6,6,9-trimethyl-6H-dibenzo[b,d]pyran-1-ol, monohydrochloride

C26H36N2O2 (408.2777)


   

Butaprost

9-oxo-11α,16S-dihydroxy-17-cyclobutyl-prost-13E-en-1-oic acid, methyl ester

C24H40O5 (408.2876)


C78568 - Prostaglandin Analogue

   

(R)-Butaprost

9-oxo-11α,16R-dihydroxy-17-cyclobutyl-prost-13E-en-1-oic acid, methyl ester

C24H40O5 (408.2876)


   

4Z,7Z,10Z,13Z,16Z,19Z,22Z,25Z-octacosaoctaenoic acid

4Z,7Z,10Z,13Z,16Z,19Z,22Z,25Z-octacosaoctaenoic acid

C28H40O2 (408.3028)


   

3a,4b,7a-Trihydroxy-5b-cholanoic acid

3a,4b,7a-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

1b,3a,12a-Trihydroxy-5b-cholanoic acid

1b,3a,12a-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

3a,4b,12a-Trihydroxy-5b-cholanoic acid

3a,4b,12a-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

1,3,12-Trihydroxycholan-24-oic acid

1,3,12-Trihydroxycholan-24-oic acid

C24H40O5 (408.2876)


   

3b,7a,12a-Trihydroxy-5a-Cholanoic acid

3b,7a,12a-Trihydroxy-5a-Cholanoic acid

C24H40O5 (408.2876)


   

3a,7b,12b-Trihydroxy-5b-cholanoic acid

3a,7b,12b-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

2b,3a,7a-Trihydroxy-5b-cholanoic acid

2b,3a,7a-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

1b,3a,7a-Trihydroxy-5b-cholanoic acid

1b,3a,7a-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

3a,6b,7b-Trihydroxy-5b-cholanoic acid

3a,6b,7b-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

3b,7a,12a-Trihydroxy-5b-cholanoic acid

3b,7a,12a-Trihydroxy-5b-cholanoic acid

C24H40O5 (408.2876)


   

3b,7b,12a-Trihydroxy-5a-Cholanoic acid

3b,7b,12a-Trihydroxy-5a-Cholanoic acid

C24H40O5 (408.2876)


   

3a,7b,12a-Trihydroxy-5a-Cholanoic acid

3a,7b,12a-Trihydroxy-5a-Cholanoic acid

C24H40O5 (408.2876)


   

Allocholic acid

Allocholic acid

C24H40O5 (408.2876)


An allo-bile acid that is 5alpha-cholan-24-oic acid bearing three alpha-hydroxy substituents at position 3, 7 and 12. D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids Allocholic acid is a typically fetal bile acid found in vertebrates and reappears during liver regeneration and carcinogenesis, besides it is also a conjugate acid of allocholate and an isomer of cholic acid. Allocholic acid is a potent and specific stimulant of the adult olfactory system, it has a role as a marine metabolite, a rat metabolite and a human metabolite[1][2][3].

   

6a,12a-Dihydroxylithocholic acid

6a,12a-Dihydroxylithocholic acid

C24H40O5 (408.2876)


   

Constanolactone E methyl acetonide

Constanolactone E methyl acetonide

C24H40O5 (408.2876)


   

Alloavicholic acid

3alpha,7alpha,16alpha-trihydroxy-5alpha-cholan-24-oic Acid

C24H40O5 (408.2876)


   

Sinapoylspermine

(2Z)-N-(3-aminopropyl)-N-{4-[(3-aminopropyl)amino]butyl}-3-(4-hydroxy-3,5-dimethoxyphenyl)prop-2-enamide

C21H36N4O4 (408.2736)


   

Apoviolaxanthinal

(2Z,4Z,6E,8E,10E,12Z,14E)-15-{4-hydroxy-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}-4,9,13-trimethylpentadeca-2,4,6,8,10,12,14-heptaenal

C27H36O3 (408.2664)


   

Ganodosterone

14-[(3E)-5,6-dimethylhept-3-en-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-6,9-diene-5,8-dione

C28H40O2 (408.3028)


   

4-{[5-(7-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

4-{[5-(7-Hydroxy-5,5,8a-trimethyl-2-methylenedecahydro-1-naphthalenyl)-3-methylpentyl]oxy}-4-oxobutanoic acid

C24H40O5 (408.2876)


   

FA 28:8

4Z,7Z,10Z,13Z,16Z,19Z,22Z,25Z-octacosaoctaenoic acid

C28H40O2 (408.3028)


   

N-(9,12-octadecadienoyl)-glutamine

N-(9Z,12Z-octadecadienoyl)-glutamine

C23H40N2O4 (408.2988)


   

1-heptadecylglycerone 3-phosphate

1-heptadecyl glycerone-3-phosphate

C20H41O6P (408.2641)


A 1-alkylglycerone 3-phosphate in which the alkyl group is specified as heptadecyl.

   

ST 28:5;O2

(22E,24R)-15alpha-hydroxyergosta-4,6,8(14),22-tetraen-3-one

C28H40O2 (408.3028)


   

Vulpecholic acid

1alpha,3alpha,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

ST 24:1;O5

(23S)-3alpha,12alpha,23-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids β-Muricholic acid is a potent and orally active biliary cholesterol-desaturating agent. β-Muricholic acid prevents cholesterol gallstones. β-Muricholic acid inhibits lipid accumulation. β-Muricholic acid has the potential for the research of nonalcoholic fatty liver disease (NAFLD)[1][2].

   

Lagocholic Acid

3alpha,7alpha,12beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

Pythocholic acid

3alpha,12alpha,16alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

(-)-Cuminone F

(-)-Cuminone F

C24H40O5 (408.2876)


   

(+)-Cuminone F

(+)-Cuminone F

C24H40O5 (408.2876)


   

METHYL 4 4 5 5-TETRAMETHYL-ALPHA-(1-(4

METHYL 4 4 5 5-TETRAMETHYL-ALPHA-(1-(4

C21H38B2O6 (408.2854)


   

cholic acid-24-13c

cholic acid-24-13c

C24H40O5 (408.2876)


   

(17β)-17-(1-Cyclohexen-1-yloxy)estra-1,3,5(10)-trien-3-yl propion ate

(17β)-17-(1-Cyclohexen-1-yloxy)estra-1,3,5(10)-trien-3-yl propion ate

C27H36O3 (408.2664)


   

Bis(dicyclohexylphosphino)methane

Bis(dicyclohexylphosphino)methane

C25H46P2 (408.3075)


   

4-Propoxyphenyl-4-Trans-PentylcyclohexylBenzoat

4-Propoxyphenyl-4-Trans-PentylcyclohexylBenzoat

C27H36O3 (408.2664)


   

TRIS(BUTYLCYCLOPENTADIENYL)SCANDIUM(III&

TRIS(BUTYLCYCLOPENTADIENYL)SCANDIUM(III&

C27H39Sc (408.2611)


   

Solanoquinone

Solanoquinone

C28H40O2 (408.3028)


   

4-Pentyloxyphenyl-4-Trans-PropylcyclohexylBenzo

4-Pentyloxyphenyl-4-Trans-PropylcyclohexylBenzo

C27H36O3 (408.2664)


   

QUINGESTANOL ACETATE

QUINGESTANOL ACETATE

C27H36O3 (408.2664)


C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C1636 - Therapeutic Steroid Hormone

   

Atiprimod dihydrochloride

Atiprimod dihydrochloride

C22H46Cl2N2 (408.3038)


C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor

   

3,4-Dihydro-2,5,7,8-tetramethyl-2-[2-(4-benzyl-1-piperazinyl)ethyl]-2H-1-benzopyran-6-ol

3,4-Dihydro-2,5,7,8-tetramethyl-2-[2-(4-benzyl-1-piperazinyl)ethyl]-2H-1-benzopyran-6-ol

C26H36N2O2 (408.2777)


   

Carbobenzyloxy-(L)-leucinyl-(L)leucinyl methoxymethylketone

Carbobenzyloxy-(L)-leucinyl-(L)leucinyl methoxymethylketone

C22H36N2O5 (408.2624)


   

3alpha,7alpha,12beta-Trihydroxy-5beta-cholanoic acid

(4R)-4-[(1S,2S,5R,7S,9R,10R,11S,14R,15R,16R)-5,9,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


3alpha,7alpha,12beta-Trihydroxy-5beta-cholanoic acid, also known as lagocholic acid, is a bile acid. Bile acids with beta-hydroxyl and carbonyl groups at the C-3,7, and/or 12 positions are bile acids usually found in the urine of healthy humans (PMID: 8743575). Bile acids are steroid acids found predominantly in the bile of mammals. The distinction between different bile acids is minute, depending only on the presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g. membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues (PMID: 11316487, 16037564, 12576301, 11907135). 3a,7a,12b-Trihydroxy-5b-cholanoic acid is a bile acid; bile acids with b-hydroxyl and carbonyl groups at the C-3,7 and/or 12 positions are bile acids usually found in the urine of healthy humans (PMID 8743575)

   

1b,3a,12a-Trihydroxy-5b-cholanoic acid

(4R)-4-[(2S,3R,5S,15R,16S)-3,5,16-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0²,⁷.0¹¹,¹⁵]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


1b,3a,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12. Bile acids are physiological detergents that facilitate excretion, absorption, and transport of fats and sterols in the intestine and liver. Bile acids are also steroidal amphipathic molecules derived from the catabolism of cholesterol. They modulate bile flow and lipid secretion, are essential for the absorption of dietary fats and vitamins, and have been implicated in the regulation of all the key enzymes involved in cholesterol homeostasis. Bile acids recirculate through the liver, bile ducts, small intestine and portal vein to form an enterohepatic circuit. They exist as anions at physiological pH and, consequently, require a carrier for transport across the membranes of the enterohepatic tissues. The unique detergent properties of bile acids are essential for the digestion and intestinal absorption of hydrophobic nutrients. Bile acids have potent toxic properties (e.g., membrane disruption) and there are a plethora of mechanisms to limit their accumulation in blood and tissues. 1b,3a,12a-Trihydroxy-5b-cholanoic acid is a bile acid. Bile acids are steroid acids found predominantly in bile of mammals. The distinction between different bile acids is minute, depends only on presence or absence of hydroxyl groups on positions 3, 7, and 12.

   

1beta-Hydroxydeoxycholic acid

1beta-Hydroxydeoxycholic acid

C24H40O5 (408.2876)


A trihydroxy-5beta-cholanic acid in which the three hydroxy groups are located at positions 1beta, 3alpha, and 12alpha.

   

Ganodesterone

Ganodesterone

C28H40O2 (408.3028)


An ergostanoid that is (22E)-ergosta-4,7,22-triene substituted by oxo groups at positions 3 and 6. It has been isolated from the fungus, Xylaria species.

   

5,6-Epoxy-3-hydroxy-12-apo-beta-caroten-12-al

5,6-Epoxy-3-hydroxy-12-apo-beta-caroten-12-al

C27H36O3 (408.2664)


   

3,5-Dihydroxy-6,7-didehydro-12-apo-beta-caroten-12-al

3,5-Dihydroxy-6,7-didehydro-12-apo-beta-caroten-12-al

C27H36O3 (408.2664)


   

methyl 7-[3-hydroxy-2-[(E)-4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxocyclopentyl]heptanoate

methyl 7-[3-hydroxy-2-[(E)-4-hydroxy-4-(1-propylcyclobutyl)but-1-enyl]-5-oxocyclopentyl]heptanoate

C24H40O5 (408.2876)


   

N-Linoleoyl Glutamine

N-Linoleoyl Glutamine

C23H40N2O4 (408.2988)


   

1-[2-Imino-3-[2-(1-piperidinyl)ethyl]-1-benzimidazolyl]-3-(3-methylphenoxy)-2-propanol

1-[2-Imino-3-[2-(1-piperidinyl)ethyl]-1-benzimidazolyl]-3-(3-methylphenoxy)-2-propanol

C24H32N4O2 (408.2525)


   

4-[5-(7-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)-3-methylpentoxy]-4-oxobutanoic acid

4-[5-(7-hydroxy-5,5,8a-trimethyl-2-methylidene-3,4,4a,6,7,8-hexahydro-1H-naphthalen-1-yl)-3-methylpentoxy]-4-oxobutanoic acid

C24H40O5 (408.2876)


   

C20 sphinganine 1-phosphate(1-)

C20 sphinganine 1-phosphate(1-)

C20H43NO5P- (408.2879)


   

4-Hydroxy-6-(13-hydroxy-2-oxononadecyl)pyran-2-one

4-Hydroxy-6-(13-hydroxy-2-oxononadecyl)pyran-2-one

C24H40O5 (408.2876)


   

N-[3-(2,6-dimethyl-1-piperidinyl)propyl]-1,5-dimethyl-4-oxo-2-pyrrolo[3,2-c]quinolinecarboxamide

N-[3-(2,6-dimethyl-1-piperidinyl)propyl]-1,5-dimethyl-4-oxo-2-pyrrolo[3,2-c]quinolinecarboxamide

C24H32N4O2 (408.2525)


   

Cholic acid-2,2,4,4-d4

Cholic acid-2,2,4,4-d4

C24H40O5 (408.2876)


   

(2S,3R)-3-farnesyl-2,3-dihydro-2,N(alpha)-cyclo-L-tryptophan

(2S,3R)-3-farnesyl-2,3-dihydro-2,N(alpha)-cyclo-L-tryptophan

C26H36N2O2 (408.2777)


   

(4R)-4-[(3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-2,2,3,4,4-pentadeuterio-3,6,7-trihydroxy-10,13-dimethyl-1,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid

(4R)-4-[(3R,5R,6S,7S,8S,9S,10R,13R,14S,17R)-2,2,3,4,4-pentadeuterio-3,6,7-trihydroxy-10,13-dimethyl-1,5,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O5 (408.2876)


   

MuricholicAcid

MuricholicAcid

C24H40O5 (408.2876)


   

[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] butanoate

[1-hydroxy-3-[(9Z,12Z,15Z)-octadeca-9,12,15-trienoxy]propan-2-yl] butanoate

C25H44O4 (408.3239)


   

[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] acetate

[1-hydroxy-3-[(11Z,14Z,17Z)-icosa-11,14,17-trienoxy]propan-2-yl] acetate

C25H44O4 (408.3239)


   

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] hexanoate

[1-[(7Z,10Z,13Z)-hexadeca-7,10,13-trienoxy]-3-hydroxypropan-2-yl] hexanoate

C25H44O4 (408.3239)


   

[3-carboxy-2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropyl]-trimethylazanium

[3-carboxy-2-[(8E,11E,14E)-heptadeca-8,11,14-trienoyl]oxypropyl]-trimethylazanium

C24H42NO4+ (408.3114)


   

2,3-dihydroxypropyl (10Z,13Z,16Z)-docosa-10,13,16-trienoate

2,3-dihydroxypropyl (10Z,13Z,16Z)-docosa-10,13,16-trienoate

C25H44O4 (408.3239)


   

Fahfa 4:0/21:2

Fahfa 4:0/21:2

C25H44O4 (408.3239)


   

Fahfa 22:2/3:0

Fahfa 22:2/3:0

C25H44O4 (408.3239)


   

Fahfa 21:2/4:0

Fahfa 21:2/4:0

C25H44O4 (408.3239)


   

Fahfa 3:0/22:2

Fahfa 3:0/22:2

C25H44O4 (408.3239)


   

Fahfa 5:0/20:2

Fahfa 5:0/20:2

C25H44O4 (408.3239)


   

Fahfa 18:2/7:0

Fahfa 18:2/7:0

C25H44O4 (408.3239)


   

Fahfa 7:0/18:2

Fahfa 7:0/18:2

C25H44O4 (408.3239)


   

Fahfa 19:2/6:0

Fahfa 19:2/6:0

C25H44O4 (408.3239)


   

Fahfa 8:0/17:2

Fahfa 8:0/17:2

C25H44O4 (408.3239)


   

Fahfa 17:2/8:0

Fahfa 17:2/8:0

C25H44O4 (408.3239)


   

Fahfa 9:0/16:2

Fahfa 9:0/16:2

C25H44O4 (408.3239)


   

Fahfa 6:0/19:2

Fahfa 6:0/19:2

C25H44O4 (408.3239)


   

Fahfa 16:2/9:0

Fahfa 16:2/9:0

C25H44O4 (408.3239)


   

Fahfa 20:2/5:0

Fahfa 20:2/5:0

C25H44O4 (408.3239)


   

(4R)-4-[(3R,5R,7R,8R,9S,10S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

(4R)-4-[(3R,5R,7R,8R,9S,10S,13R,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O5 (408.2876)


   

(1-hydroxy-3-propanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

(1-hydroxy-3-propanoyloxypropan-2-yl) (9Z,12Z,15Z)-octadeca-9,12,15-trienoate

C24H40O5 (408.2876)


   

(1-hydroxy-3-pentanoyloxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

(1-hydroxy-3-pentanoyloxypropan-2-yl) (7Z,10Z,13Z)-hexadeca-7,10,13-trienoate

C24H40O5 (408.2876)


   

4-[(3R,5S,7R,8R,9S,12S,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

4-[(3R,5S,7R,8R,9S,12S,14S,17R)-3,7,12-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O5 (408.2876)


   

4-[(3R,5R,6R,7S,8S,9S,14S,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

4-[(3R,5R,6R,7S,8S,9S,14S,17R)-3,6,7-trihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoic acid

C24H40O5 (408.2876)


   

3-hydroxy-1,2-dimethyl-4-[4-methyl-2-[(E)-2-methyltetradec-4-en-6,8-diynyl]-3,4-dihydro-2H-pyrrol-5-yl]-2H-pyrrol-5-one

3-hydroxy-1,2-dimethyl-4-[4-methyl-2-[(E)-2-methyltetradec-4-en-6,8-diynyl]-3,4-dihydro-2H-pyrrol-5-yl]-2H-pyrrol-5-one

C26H36N2O2 (408.2777)


   

beta-muricholic acid

beta-muricholic acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids β-Muricholic acid is a potent and orally active biliary cholesterol-desaturating agent. β-Muricholic acid prevents cholesterol gallstones. β-Muricholic acid inhibits lipid accumulation. β-Muricholic acid has the potential for the research of nonalcoholic fatty liver disease (NAFLD)[1][2].

   

omega-muricholic acid

omega-muricholic acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

3alpha,7alpha,12beta-Trihydroxy-5beta-cholanic acid

3alpha,7alpha,12beta-Trihydroxy-5beta-cholanic acid

C24H40O5 (408.2876)


A trihydroxy-5beta-cholanic acid that is 5beta-cholan-24-oic acid substituted by hydroxy groups at positions 3, 7 and 12 (the 3alpha,7alpha,12beta stereoisomer).

   

2beta,3alpha,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

2beta,3alpha,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

1beta,3alpha,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

1beta,3alpha,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

Muricholic acid

Muricholic acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

Apo-10-violaxanthal

Apo-10-violaxanthal

C27H36O3 (408.2664)


   

3beta,5alpha,6beta-Trihydroxycholan-24-oic Acid

3beta,5alpha,6beta-Trihydroxycholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,4beta,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,4beta,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

3alpha,6beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,6beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3beta,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

3beta,6alpha,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,12alpha,16alpha-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,12alpha,16alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


D005765 - Gastrointestinal Agents > D001647 - Bile Acids and Salts D005765 - Gastrointestinal Agents > D002793 - Cholic Acids

   

3beta,4beta,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

3beta,4beta,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3beta,6alpha,7beta-Trihydroxy-5beta-cholan-24-oic Acid

3beta,6alpha,7beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3beta,6beta,7beta-Trihydroxy-5beta-cholan-24-oic Acid

3beta,6beta,7beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3beta,6beta,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

3beta,6beta,7alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

(23S)-3alpha,7alpha,23-Trihydroxy-5beta-cholan-24-oic Acid

(23S)-3alpha,7alpha,23-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

(23S)-3alpha,12alpha,23-Trihydroxy-5beta-cholan-24-oic Acid

(23S)-3alpha,12alpha,23-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,7beta,21chi-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,7beta,21chi-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,11beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,11beta,12beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,12alpha,15alpha-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,12alpha,15alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,11beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,11beta,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,11alpha,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,11alpha,12alpha-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

3alpha,11alpha,12beta-Trihydroxy-5beta-cholan-24-oic Acid

3alpha,11alpha,12beta-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

(22R)-3alpha,7alpha,22-Trihydroxy-5beta-cholan-24-oic Acid

(22R)-3alpha,7alpha,22-Trihydroxy-5beta-cholan-24-oic Acid

C24H40O5 (408.2876)


   

DG(22:3)

DG(12:0(1)_10:3)

C25H44O4 (408.3239)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

Octacosaoctaenoic acid

Octacosaoctaenoic acid

C28H40O2 (408.3028)


   

NA-Arg 17:2(9Z,12Z)

NA-Arg 17:2(9Z,12Z)

C22H40N4O3 (408.31)


   

NA-Gln 18:2(9E,12E)

NA-Gln 18:2(9E,12E)

C23H40N2O4 (408.2988)


   

NA-Gln 18:2(9Z,12Z)

NA-Gln 18:2(9Z,12Z)

C23H40N2O4 (408.2988)


   

NA-Tryptamine 17:2(9Z,12Z)

NA-Tryptamine 17:2(9Z,12Z)

C27H40N2O (408.314)


   

FAHFA 10:0/O-15:2

FAHFA 10:0/O-15:2

C25H44O4 (408.3239)


   

FAHFA 10:1/O-15:1

FAHFA 10:1/O-15:1

C25H44O4 (408.3239)


   

FAHFA 10:2/O-15:0

FAHFA 10:2/O-15:0

C25H44O4 (408.3239)


   

FAHFA 11:0/O-14:2

FAHFA 11:0/O-14:2

C25H44O4 (408.3239)


   

FAHFA 11:1/O-14:1

FAHFA 11:1/O-14:1

C25H44O4 (408.3239)


   

FAHFA 11:2/O-14:0

FAHFA 11:2/O-14:0

C25H44O4 (408.3239)


   

FAHFA 12:0/O-13:2

FAHFA 12:0/O-13:2

C25H44O4 (408.3239)


   

FAHFA 12:1/O-13:1

FAHFA 12:1/O-13:1

C25H44O4 (408.3239)


   

FAHFA 12:2/O-13:0

FAHFA 12:2/O-13:0

C25H44O4 (408.3239)


   

FAHFA 13:0/O-12:2

FAHFA 13:0/O-12:2

C25H44O4 (408.3239)


   

FAHFA 13:1/O-12:1

FAHFA 13:1/O-12:1

C25H44O4 (408.3239)


   

FAHFA 13:2/O-12:0

FAHFA 13:2/O-12:0

C25H44O4 (408.3239)


   

FAHFA 14:0/O-11:2

FAHFA 14:0/O-11:2

C25H44O4 (408.3239)


   

FAHFA 14:1/O-11:1

FAHFA 14:1/O-11:1

C25H44O4 (408.3239)


   

Trihydroxycholanoic acid

Trihydroxycholanoic acid

C24H40O5 (408.2876)


   
   

LSM(14:1)

LSM(d14:1)

C19H41N2O5P (408.2753)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

ω-muricholate

(4R)-4-[(1S,2R,5R,7R,8R,9R,10S,11S,14R,15R)-5,8,9-trihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]pentanoic acid

C24H40O5 (408.2876)


-

   

3,4,5,7-tetraethyl-1-methyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

3,4,5,7-tetraethyl-1-methyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

(2r)-2-[(3r,6s)-6-[(3e)-6-[(1r)-1-hydroxy-2,2-dimethyl-6-methylidenecyclohexyl]-4-methylhex-3-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(3r,6s)-6-[(3e)-6-[(1r)-1-hydroxy-2,2-dimethyl-6-methylidenecyclohexyl]-4-methylhex-3-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

(2r)-2-[(6r)-6-methyl-6-{2-[(2s,3s)-3-methyl-3-[2-(2,6,6-trimethylcyclohex-1-en-1-yl)ethyl]oxiran-2-yl]ethyl}-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(6r)-6-methyl-6-{2-[(2s,3s)-3-methyl-3-[2-(2,6,6-trimethylcyclohex-1-en-1-yl)ethyl]oxiran-2-yl]ethyl}-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

1-(5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,3ah,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthrene-5,7-dione

C28H40O2 (408.3028)


   

(1r,9ar,9br,11ar)-1-[(2r,3e,5s)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,9ar,9br,11ar)-1-[(2r,3e,5s)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H40O2 (408.3028)


   

(3r)-n-{2-[(7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxytetradecanimidic acid

(3r)-n-{2-[(7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxytetradecanimidic acid

C22H36N2O5 (408.2624)


   

(2r)-2-[(6r)-6-methyl-6-[(3e)-4-methyl-6-{2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}hex-3-en-1-yl]-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(6r)-6-methyl-6-[(3e)-4-methyl-6-{2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}hex-3-en-1-yl]-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

(2r,4ar,8r,8as)-8-[(3s)-5-hydroxy-3-methylpentyl]-4,4,7,8a-tetramethyl-1,2,3,4a,5,8-hexahydronaphthalen-2-yl 1-methyl propanedioate

(2r,4ar,8r,8as)-8-[(3s)-5-hydroxy-3-methylpentyl]-4,4,7,8a-tetramethyl-1,2,3,4a,5,8-hexahydronaphthalen-2-yl 1-methyl propanedioate

C24H40O5 (408.2876)


   

2-[6-methyl-6-(4-methyl-6-{2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}hex-3-en-1-yl)-1,2-dioxan-3-yl]propanoic acid

2-[6-methyl-6-(4-methyl-6-{2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}hex-3-en-1-yl)-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

2,4-dihydroxy-6-[(12s)-12-hydroxyheptadecyl]benzoic acid

2,4-dihydroxy-6-[(12s)-12-hydroxyheptadecyl]benzoic acid

C24H40O5 (408.2876)


   

2,4-dihydroxy-6-(12-hydroxyheptadecyl)benzoic acid

2,4-dihydroxy-6-(12-hydroxyheptadecyl)benzoic acid

C24H40O5 (408.2876)


   

1-[5-(2-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl)-3-methylpent-2-en-1-yl] 3-methyl propanedioate

1-[5-(2-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl)-3-methylpent-2-en-1-yl] 3-methyl propanedioate

C24H40O5 (408.2876)


   

4-hydroxy-3-[(2r)-2-hydroxypentadecyl]-5-methoxyphenyl acetate

4-hydroxy-3-[(2r)-2-hydroxypentadecyl]-5-methoxyphenyl acetate

C24H40O5 (408.2876)


   

(2r,4r,6r,8r,13r)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

(2r,4r,6r,8r,13r)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

C24H40O5 (408.2876)


   

3-hydroxy-n-(2-{3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene}acetyl)tetradecanimidic acid

3-hydroxy-n-(2-{3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene}acetyl)tetradecanimidic acid

C22H36N2O5 (408.2624)


   

(3r)-n-{2-[(1e,7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxytetradecanimidic acid

(3r)-n-{2-[(1e,7ar)-3-oxo-tetrahydropyrrolo[1,2-c][1,3]oxazol-1-ylidene]acetyl}-3-hydroxytetradecanimidic acid

C22H36N2O5 (408.2624)


   

(1r,3r,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3r,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H40O2 (408.3028)


   

(2r)-2-[(3s,6r)-6-methyl-6-[(3e)-4-methyl-6-{2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}hex-3-en-1-yl]-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(3s,6r)-6-methyl-6-[(3e)-4-methyl-6-{2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}hex-3-en-1-yl]-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

(2s,4r,6r,8r,13s)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

(2s,4r,6r,8r,13s)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

C24H40O5 (408.2876)


   

16-hydroxy-7-[hydroxy(phenyl)methyl]-5,5,9,16-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-13-en-6-one

16-hydroxy-7-[hydroxy(phenyl)methyl]-5,5,9,16-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-13-en-6-one

C27H36O3 (408.2664)


   

14-hydroxy-1-(2,4,6-trihydroxyphenyl)octadecan-1-one

14-hydroxy-1-(2,4,6-trihydroxyphenyl)octadecan-1-one

C24H40O5 (408.2876)


   

(1s,9r)-11-methyl-5-[(1s,4r,9r)-11-methyl-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-yl]-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

(1s,9r)-11-methyl-5-[(1s,4r,9r)-11-methyl-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-yl]-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C24H32N4O2 (408.2525)


   

(4r,5r)-4-[(1e,3e,5e,7e,9e)-10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-2,4,5-trimethylcyclopent-2-en-1-one

(4r,5r)-4-[(1e,3e,5e,7e,9e)-10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl]-2,4,5-trimethylcyclopent-2-en-1-one

C27H36O3 (408.2664)


   

(3s)-5-[(1r,4as,6r,7s,8as)-7-(acetyloxy)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentyl acetate

(3s)-5-[(1r,4as,6r,7s,8as)-7-(acetyloxy)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentyl acetate

C24H40O5 (408.2876)


   

(3r,3ar,8s,11br)-3-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-8-hydroxy-3a,6-dimethyl-1h,2h,3h,4h,7h,8h,9h,10h,11bh-cyclopenta[a]anthracen-5-one

(3r,3ar,8s,11br)-3-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-8-hydroxy-3a,6-dimethyl-1h,2h,3h,4h,7h,8h,9h,10h,11bh-cyclopenta[a]anthracen-5-one

C28H40O2 (408.3028)


   

(4ar,4br,6ar,11ar,11br,13ar)-1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

(4ar,4br,6ar,11ar,11br,13ar)-1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

C27H36O3 (408.2664)


   

4-[5-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2-methylpent-2-en-1-yl]-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

4-[5-(6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl)-2-methylpent-2-en-1-yl]-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

C27H36O3 (408.2664)


   

1-(5,6-dimethylhept-3-en-2-yl)-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(5,6-dimethylhept-3-en-2-yl)-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H40O2 (408.3028)


   

(2r,4r,6r,8s,13r)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

(2r,4r,6r,8s,13r)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

C24H40O5 (408.2876)


   

(1r,7s,9ar,9br,11ar)-1-[(2s,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-one

(1r,7s,9ar,9br,11ar)-1-[(2s,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-one

C28H40O2 (408.3028)


   

1-(2e)-5-[(1r,2r,4as,8as)-2-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl 3-methyl propanedioate

1-(2e)-5-[(1r,2r,4as,8as)-2-hydroxy-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-3-methylpent-2-en-1-yl 3-methyl propanedioate

C24H40O5 (408.2876)


   

(2r)-2-[(3r,6s)-6-[3-hydroxy-4-methylidene-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(3r,6s)-6-[3-hydroxy-4-methylidene-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

2-{3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl}-2-(acetyloxy)ethyl acetate

2-{3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl}-2-(acetyloxy)ethyl acetate

C24H40O5 (408.2876)


   

1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-1h,2h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-1h,2h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H40O2 (408.3028)


   

(2s)-2-[(3r,6r)-6-[(3s)-3-hydroxy-4-methylidene-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

(2s)-2-[(3r,6r)-6-[(3s)-3-hydroxy-4-methylidene-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hexyl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

(2r)-2-[(3s,6r)-6-methyl-6-(4-methyl-6-{2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}hex-3-en-1-yl)-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(3s,6r)-6-methyl-6-(4-methyl-6-{2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl}hex-3-en-1-yl)-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

(2r)-2-[(3s,6r)-6-[(3e)-6-(1-hydroxy-2,2-dimethyl-6-methylidenecyclohexyl)-4-methylhex-3-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(3s,6r)-6-[(3e)-6-(1-hydroxy-2,2-dimethyl-6-methylidenecyclohexyl)-4-methylhex-3-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

(1s,2r,5s,7r,8r,12s)-7-(acetyloxy)-2,8,12-trimethyl-10-oxo-5-(prop-1-en-2-yl)cyclotetradecyl acetate

(1s,2r,5s,7r,8r,12s)-7-(acetyloxy)-2,8,12-trimethyl-10-oxo-5-(prop-1-en-2-yl)cyclotetradecyl acetate

C24H40O5 (408.2876)


   

1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

C27H36O3 (408.2664)


   

(2e,6z,11s,12r)-7-[(acetyloxy)methyl]-12-hydroxy-3,11,15-trimethylhexadeca-2,6,14-trien-1-yl acetate

(2e,6z,11s,12r)-7-[(acetyloxy)methyl]-12-hydroxy-3,11,15-trimethylhexadeca-2,6,14-trien-1-yl acetate

C24H40O5 (408.2876)


   

4-{4,7-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl}-2-hydroxypentanoic acid

4-{4,7-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl}-2-hydroxypentanoic acid

C24H40O5 (408.2876)


   

(1r,9ar,11ar)-1-[(2r,3e)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,9ar,11ar)-1-[(2r,3e)-6-hydroxy-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H40O2 (408.3028)


   

4-hydroxy-5-(12-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl)-2,3-dimethoxy-6-methylcyclohex-2-en-1-one

4-hydroxy-5-(12-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl)-2,3-dimethoxy-6-methylcyclohex-2-en-1-one

C24H40O5 (408.2876)


   

2,4-dihydroxy-6-[(15r)-15-hydroxyheptadecyl]benzoic acid

2,4-dihydroxy-6-[(15r)-15-hydroxyheptadecyl]benzoic acid

C24H40O5 (408.2876)


   

(1r,4s,7r,9s,10s,12r,16s)-16-hydroxy-7-[(s)-hydroxy(phenyl)methyl]-5,5,9,16-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-13-en-6-one

(1r,4s,7r,9s,10s,12r,16s)-16-hydroxy-7-[(s)-hydroxy(phenyl)methyl]-5,5,9,16-tetramethyltetracyclo[10.2.2.0¹,¹⁰.0⁴,⁹]hexadec-13-en-6-one

C27H36O3 (408.2664)


   

4-{7,11-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl}-2-hydroxypentanoic acid

4-{7,11-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl}-2-hydroxypentanoic acid

C24H40O5 (408.2876)


   

(3s)-3-{2-[(1s,2r,4ar,8ar)-5-[(acetyloxy)methyl]-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-4-hydroxybutyl acetate

(3s)-3-{2-[(1s,2r,4ar,8ar)-5-[(acetyloxy)methyl]-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-4-hydroxybutyl acetate

C24H40O5 (408.2876)


   

(4r,5r)-4-{5-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2-methylpent-2-en-1-yl}-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

(4r,5r)-4-{5-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2-methylpent-2-en-1-yl}-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

C27H36O3 (408.2664)


   

(2r)-2-{2-[(1s,2r,4ar,8ar)-5-(hydroxymethyl)-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-4-(acetyloxy)butyl acetate

(2r)-2-{2-[(1s,2r,4ar,8ar)-5-(hydroxymethyl)-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]ethyl}-4-(acetyloxy)butyl acetate

C24H40O5 (408.2876)


   

(2s)-2-[(3r,6r)-6-[(2e,4s)-4-hydroxy-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-2-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

(2s)-2-[(3r,6r)-6-[(2e,4s)-4-hydroxy-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-2-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

7-(acetyloxy)-2,8,12-trimethyl-10-oxo-5-(prop-1-en-2-yl)cyclotetradecyl acetate

7-(acetyloxy)-2,8,12-trimethyl-10-oxo-5-(prop-1-en-2-yl)cyclotetradecyl acetate

C24H40O5 (408.2876)


   

1-[2-(acetyloxy)-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-3-hydroxy-3-methylpent-4-en-2-yl acetate

1-[2-(acetyloxy)-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-3-hydroxy-3-methylpent-4-en-2-yl acetate

C24H40O5 (408.2876)


   

(1s,3s,3ar,4r,5s,7ar)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1s,3s,3ar,4r,5s,7ar)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

(2r,4r,6r,8r,13s)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

(2r,4r,6r,8r,13s)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

C24H40O5 (408.2876)


   

(8s)-10-{[(1s,3s,4r,6r,8s)-3-(hydroxymethyl)-6-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-1-yl]methyl}-11-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one

(8s)-10-{[(1s,3s,4r,6r,8s)-3-(hydroxymethyl)-6-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-1-yl]methyl}-11-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one

C26H36N2O2 (408.2777)


   

2,4-dihydroxy-6-[(16r)-16-hydroxyheptadecyl]benzoic acid

2,4-dihydroxy-6-[(16r)-16-hydroxyheptadecyl]benzoic acid

C24H40O5 (408.2876)


   

1-(5-hydroxy-5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(5-hydroxy-5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H40O2 (408.3028)


   

(2e,11s,12r)-7-[(acetyloxy)methyl]-12-hydroxy-3,11,15-trimethylhexadeca-2,6,14-trien-1-yl acetate

(2e,11s,12r)-7-[(acetyloxy)methyl]-12-hydroxy-3,11,15-trimethylhexadeca-2,6,14-trien-1-yl acetate

C24H40O5 (408.2876)


   

(14s)-14-hydroxy-1-(2,4,6-trihydroxyphenyl)octadecan-1-one

(14s)-14-hydroxy-1-(2,4,6-trihydroxyphenyl)octadecan-1-one

C24H40O5 (408.2876)


   

(1r,3s,9ar,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3s,9ar,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H40O2 (408.3028)


   

(4r,5r)-4-{10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl}-2,4,5-trimethylcyclopent-2-en-1-one

(4r,5r)-4-{10-[(2s,5r,6r)-5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl]undeca-1,3,5,7,9-pentaen-1-yl}-2,4,5-trimethylcyclopent-2-en-1-one

C27H36O3 (408.2664)


   

(1r,2r,6r,7r,8r,9r,12s,13r)-12,13-dihydroxy-6-isopropyl-9,13-dimethyl-3-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

(1r,2r,6r,7r,8r,9r,12s,13r)-12,13-dihydroxy-6-isopropyl-9,13-dimethyl-3-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

C24H40O5 (408.2876)


   

(3s)-5-[(1r,4as,6s,7s,8as)-7-(acetyloxy)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentyl acetate

(3s)-5-[(1r,4as,6s,7s,8as)-7-(acetyloxy)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentyl acetate

C24H40O5 (408.2876)


   

(2r)-2-[(3s,6r)-6-[6-(1-hydroxy-2,2-dimethyl-6-methylidenecyclohexyl)-4-methylhex-3-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(3s,6r)-6-[6-(1-hydroxy-2,2-dimethyl-6-methylidenecyclohexyl)-4-methylhex-3-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

1-[5-(5-hydroxy-3-methylpentyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[5-(5-hydroxy-3-methylpentyl)-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C24H40O5 (408.2876)


   

4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

C24H40O5 (408.2876)


   

5-[7-(acetyloxy)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentyl acetate

5-[7-(acetyloxy)-6-hydroxy-2,5,5,8a-tetramethyl-1,4,4a,6,7,8-hexahydronaphthalen-1-yl]-3-methylpentyl acetate

C24H40O5 (408.2876)


   

(4r,5r,6r)-4-hydroxy-5-(12-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl)-2,3-dimethoxy-6-methylcyclohex-2-en-1-one

(4r,5r,6r)-4-hydroxy-5-(12-hydroxy-3,7,11-trimethyldodeca-2,6-dien-1-yl)-2,3-dimethoxy-6-methylcyclohex-2-en-1-one

C24H40O5 (408.2876)


   

(1r,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

(1r,7s,9as,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,6h,7h,8h,9h,10h,11h-cyclopenta[a]phenanthren-4-one

C28H40O2 (408.3028)


   

6,10-dimethyl-12-(5-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienal

6,10-dimethyl-12-(5-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienal

C27H36O3 (408.2664)


   

2-[(3s,4ar,6as,10as,10br)-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-(acetyloxy)ethyl acetate

2-[(3s,4ar,6as,10as,10br)-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-(acetyloxy)ethyl acetate

C24H40O5 (408.2876)


   

(4r,5r)-4-[(2e)-5-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2-methylpent-2-en-1-yl]-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

(4r,5r)-4-[(2e)-5-[(2r)-6-hydroxy-2,8-dimethyl-3,4-dihydro-1-benzopyran-2-yl]-2-methylpent-2-en-1-yl]-2-methyl-5-(2-methylprop-1-en-1-yl)cyclopent-2-en-1-one

C27H36O3 (408.2664)


   

1-(6-hydroxy-5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

1-(6-hydroxy-5,6-dimethylhept-3-en-2-yl)-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H40O2 (408.3028)


   

(2s)-2-[(3r,6r)-6-[(2e)-4-hydroxy-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-2-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

(2s)-2-[(3r,6r)-6-[(2e)-4-hydroxy-4-methyl-6-(2,6,6-trimethylcyclohex-1-en-1-yl)hex-2-en-1-yl]-6-methyl-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

(2r,4s)-4-[(1r,3ar,3bs,5as,7r,9as,9br,11s,11ar)-7,11-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-hydroxypentanoic acid

(2r,4s)-4-[(1r,3ar,3bs,5as,7r,9as,9br,11s,11ar)-7,11-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-hydroxypentanoic acid

C24H40O5 (408.2876)


   

3-[14-(4-hydroxy-5-methyl-2-oxooxolan-3-yl)tetradecyl]-5-methyl-5h-furan-2-one

3-[14-(4-hydroxy-5-methyl-2-oxooxolan-3-yl)tetradecyl]-5-methyl-5h-furan-2-one

C24H40O5 (408.2876)


   

(1s,2s,6s,7s,8s,9s,12r,13r)-12,13-dihydroxy-6-isopropyl-9,13-dimethyl-3-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

(1s,2s,6s,7s,8s,9s,12r,13r)-12,13-dihydroxy-6-isopropyl-9,13-dimethyl-3-methylidene-15-oxatricyclo[6.6.1.0²,⁷]pentadecan-9-yl butanoate

C24H40O5 (408.2876)


   

(1s,3s,3ar,4r,5s,7ar)-3,4,5,7-tetraethyl-1-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1s,3s,3ar,4r,5s,7ar)-3,4,5,7-tetraethyl-1-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

3-(5,6-dimethylhept-3-en-2-yl)-8-hydroxy-3a,6-dimethyl-1h,2h,3h,4h,7h,8h,9h,10h,11bh-cyclopenta[a]anthracen-5-one

3-(5,6-dimethylhept-3-en-2-yl)-8-hydroxy-3a,6-dimethyl-1h,2h,3h,4h,7h,8h,9h,10h,11bh-cyclopenta[a]anthracen-5-one

C28H40O2 (408.3028)


   

(2r,4s)-4-[(1r,3as,3br,4r,5as,7r,9as,9bs,11ar)-4,7-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-hydroxypentanoic acid

(2r,4s)-4-[(1r,3as,3br,4r,5as,7r,9as,9bs,11ar)-4,7-dihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]-2-hydroxypentanoic acid

C24H40O5 (408.2876)


   

(2r)-2-[(3s,6r)-6-methyl-6-{2-[(2s,3s)-3-methyl-3-[2-(2,6,6-trimethylcyclohex-1-en-1-yl)ethyl]oxiran-2-yl]ethyl}-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(3s,6r)-6-methyl-6-{2-[(2s,3s)-3-methyl-3-[2-(2,6,6-trimethylcyclohex-1-en-1-yl)ethyl]oxiran-2-yl]ethyl}-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

4-hydroxy-3-(2-hydroxypentadecyl)-5-methoxyphenyl acetate

4-hydroxy-3-(2-hydroxypentadecyl)-5-methoxyphenyl acetate

C24H40O5 (408.2876)


   

(2e,6e,10e)-6,10-dimethyl-12-(5-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienal

(2e,6e,10e)-6,10-dimethyl-12-(5-methyl-3,6-dioxocyclohexa-1,4-dien-1-yl)-2-(4-methylpent-3-en-1-yl)dodeca-2,6,10-trienal

C27H36O3 (408.2664)


   

(2r,3r)-1-[(1r,2r,4as,8as)-2-(acetyloxy)-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-3-hydroxy-3-methylpent-4-en-2-yl acetate

(2r,3r)-1-[(1r,2r,4as,8as)-2-(acetyloxy)-2,5,5,8a-tetramethyl-hexahydro-1h-naphthalen-1-yl]-3-hydroxy-3-methylpent-4-en-2-yl acetate

C24H40O5 (408.2876)


   

(1s)-1-[(3s,4ar,6as,10as,10br)-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-(acetyloxy)ethyl acetate

(1s)-1-[(3s,4ar,6as,10as,10br)-3,4a,7,7,10a-pentamethyl-octahydro-1h-naphtho[2,1-b]pyran-3-yl]-2-(acetyloxy)ethyl acetate

C24H40O5 (408.2876)


   

3-(2-{5-[(acetyloxy)methyl]-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl}ethyl)-4-hydroxybutyl acetate

3-(2-{5-[(acetyloxy)methyl]-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl}ethyl)-4-hydroxybutyl acetate

C24H40O5 (408.2876)


   

(4r)-4-[(1r,3as,3br,5as,7r,9as,9bs,11s,11ar)-4,7,11-trihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

(4r)-4-[(1r,3as,3br,5as,7r,9as,9bs,11s,11ar)-4,7,11-trihydroxy-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]pentanoic acid

C24H40O5 (408.2876)


   

1-[(4ar,5s,6r,8ar)-5-[(3s)-5-hydroxy-3-methylpentyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

1-[(4ar,5s,6r,8ar)-5-[(3s)-5-hydroxy-3-methylpentyl]-5,6,8a-trimethyl-3,4,4a,6,7,8-hexahydronaphthalen-1-yl]methyl 3-methyl propanedioate

C24H40O5 (408.2876)


   

2,4-dihydroxy-6-(15-hydroxyheptadecyl)benzoic acid

2,4-dihydroxy-6-(15-hydroxyheptadecyl)benzoic acid

C24H40O5 (408.2876)


   

2-[6-(acetyloxy)-4-methylhex-4-en-1-ylidene]-7-hydroxy-6,10-dimethylundec-9-en-1-yl acetate

2-[6-(acetyloxy)-4-methylhex-4-en-1-ylidene]-7-hydroxy-6,10-dimethylundec-9-en-1-yl acetate

C24H40O5 (408.2876)


   

11-methyl-5-{11-methyl-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-yl}-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

11-methyl-5-{11-methyl-6-oxo-7,11-diazatricyclo[7.3.1.0²,⁷]tridec-2-en-4-yl}-7,11-diazatricyclo[7.3.1.0²,⁷]trideca-2,4-dien-6-one

C24H32N4O2 (408.2525)


   

3-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-2,5-dihydro-1-benzoxepine-7-carboxylic acid

3-(4,8,12-trimethyltrideca-3,7,11-trien-1-yl)-2,5-dihydro-1-benzoxepine-7-carboxylic acid

C27H36O3 (408.2664)


   

(2r)-2-[(3r,6r)-6-methyl-6-[(3e)-4-methyl-6-[(1s,6r)-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]hex-3-en-1-yl]-1,2-dioxan-3-yl]propanoic acid

(2r)-2-[(3r,6r)-6-methyl-6-[(3e)-4-methyl-6-[(1s,6r)-2,2,6-trimethyl-7-oxabicyclo[4.1.0]heptan-1-yl]hex-3-en-1-yl]-1,2-dioxan-3-yl]propanoic acid

C24H40O5 (408.2876)


   

4-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl]-2,4,5-trimethylcyclopent-2-en-1-one

4-[10-(5-hydroxy-3,5,6-trimethyl-2,6-dihydropyran-2-yl)undeca-1,3,5,7,9-pentaen-1-yl]-2,4,5-trimethylcyclopent-2-en-1-one

C27H36O3 (408.2664)


   

(4ar,4br,6ar,11ar,11bs,13ar)-1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

(4ar,4br,6ar,11ar,11bs,13ar)-1,1,4a,6a,9,11b-hexamethyl-3h,4h,4bh,5h,6h,11h,11ah,12h,13h,13ah-indeno[2,1-a]phenanthrene-2,7,10-trione

C27H36O3 (408.2664)


   

1,4,5,7-tetraethyl-3-methyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

1,4,5,7-tetraethyl-3-methyl-2-oxo-5-(2-phenylethenyl)-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

(1r,3s,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,3s,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-3-hydroxy-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H40O2 (408.3028)


   

(5r)-3-{14-[(3s,4r,5r)-4-hydroxy-5-methyl-2-oxooxolan-3-yl]tetradecyl}-5-methyl-5h-furan-2-one

(5r)-3-{14-[(3s,4r,5r)-4-hydroxy-5-methyl-2-oxooxolan-3-yl]tetradecyl}-5-methyl-5h-furan-2-one

C24H40O5 (408.2876)


   

(2s,4r,6s,8r,13s)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

(2s,4r,6s,8r,13s)-4,13-dihydroxy-2-undecyl-1,7-dioxadispiro[5.1.5⁸.2⁶]pentadec-9-en-11-one

C24H40O5 (408.2876)


   

[(1s,2r,4as,4br,8ar,10as)-1-[(acetyloxy)methyl]-2-hydroxy-4b,8,8,10a-tetramethyl-decahydrophenanthren-2-yl]methyl acetate

[(1s,2r,4as,4br,8ar,10as)-1-[(acetyloxy)methyl]-2-hydroxy-4b,8,8,10a-tetramethyl-decahydrophenanthren-2-yl]methyl acetate

C24H40O5 (408.2876)


   

2,4-dihydroxy-6-(16-hydroxyheptadecyl)benzoic acid

2,4-dihydroxy-6-(16-hydroxyheptadecyl)benzoic acid

C24H40O5 (408.2876)


   

(1r,7s,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-one

(1r,7s,9ar,9br,11ar)-1-[(2r,3e,5r)-5,6-dimethylhept-3-en-2-yl]-7-hydroxy-9a,11a-dimethyl-1h,2h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-one

C28H40O2 (408.3028)


   

4-(acetyloxy)-2-{2-[5-(hydroxymethyl)-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]ethyl}butyl acetate

4-(acetyloxy)-2-{2-[5-(hydroxymethyl)-1,2,4a-trimethyl-2,3,4,7,8,8a-hexahydronaphthalen-1-yl]ethyl}butyl acetate

C24H40O5 (408.2876)


   

10-{[(1s,3s,4r,6r,8s)-3-(hydroxymethyl)-6-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-1-yl]methyl}-11-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one

10-{[(1s,3s,4r,6r,8s)-3-(hydroxymethyl)-6-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodecan-1-yl]methyl}-11-methyl-12-azatricyclo[6.3.1.0⁴,¹²]dodeca-1,3,10-trien-5-one

C26H36N2O2 (408.2777)


   

(1r,3r,3as,4s,5s,7as)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1r,3r,3as,4s,5s,7as)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-1h,2h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-one

1-(5,6-dimethylhept-3-en-2-yl)-7-hydroxy-9a,11a-dimethyl-1h,2h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-3-one

C28H40O2 (408.3028)


   

(1r,3r,3as,4s,5r,7as)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

(1r,3r,3as,4s,5r,7as)-1,4,5,7-tetraethyl-3-methyl-2-oxo-5-[(1e)-2-phenylethenyl]-1,3,3a,7a-tetrahydroindene-4-carboxylic acid

C27H36O3 (408.2664)


   

(1r,9ar,9br,11ar)-1-[(2r)-5-hydroxy-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

(1r,9ar,9br,11ar)-1-[(2r)-5-hydroxy-5,6-dimethylhept-3-en-2-yl]-9a,11a-dimethyl-1h,2h,3h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-one

C28H40O2 (408.3028)